Data presented on the EURneffy/neffy adrenaline (epinephrine) nasal spray at the European Academy of Allergy & Clinical ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

Vaccine experts have developed an antibody that, when applied to the nose, intercepts allergens before they can trigger a ...

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...

ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.

A rapidly growing weed may cause hayfever sufferers to battle symptoms longer this year as it could pose a threat to ...

SoundHealth, the medical technology company behind the SONU Band, has launched the first-ever medical-grade Android app ...

Allergic rhinitis, often called hay fever, mimics cold symptoms but isn’t caused by a virus or bacteria. Non-allergic rhinitis, triggered by irritants like smoke, strong odours, or weather changes, ...

After spending a day outside during peak hay fever season, you can be “literally coated in pollen”, Dr Bull says. When you ...

Lupin launches Ipratropium Bromide Nasal Solution in the US market; eyes expanding complex generics pipeline to over 200 ...